All In MedTech

FDA Clearance Tracker · K260082

TRIOS Dx (R1)

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Apr 10, 2026 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

Decided

Apr 10, 2026

Substantially Equivalent

Time to decision

88 days

Received Jan 12, 2026. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K260082
Device name
TRIOS Dx (R1)
Applicant location
Copenhagen, DK
Received
Jan 12, 2026
Decided
Apr 10, 2026
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 872.1770

Every decision under product code SHQ

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code SHQ (Dental Image Analyzer, In-Office).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for 3Shape TRIOS A/S

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.